MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
VolitionRx Limited Total Non Current Liabilities 2011-2026 | VNRX
Annual Total Non Current Liabilities VolitionRx Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 3.45 M | 3.23 M | 3.02 M | 2.38 M | 1.52 M | 548 K | 352 K | 430 K | 630 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.45 M | 352 K | 1.73 M |
Quarterly Total Non Current Liabilities VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 M | 32.6 M | 29.3 M | 27.7 M | 5.04 M | 4.99 M | 4.56 M | 4.83 M | 3.24 M | - | - | 4.04 M | - | - | - | - | - | - | - | - | - | - | - | - | 2.73 M | - | 2.85 M | 3.02 M | - | - | 3.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 M | 2.73 M | 11.3 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.34 | -1.86 % | $ 179 M |  China |
|
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
3.29 B | $ 111.53 | -2.92 % | $ 33.9 B |  USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 23.84 | -3.5 % | $ 662 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
574 K | $ 1.58 | -3.07 % | $ 2.1 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 19.79 | -9.68 % | $ 1.05 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 14.8 | -3.27 % | $ 447 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 122.56 | -3.44 % | $ 19.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 165.31 | -0.84 % | $ 8.19 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
91.4 M | $ 80.34 | -3.34 % | $ 10.1 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 9.06 | -3.05 % | $ 1.97 B | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 81.05 | -2.99 % | $ 5.47 B | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 25.65 | -5.47 % | $ 20 B |  Niderland |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.96 | 1.5 % | $ 8.67 M | USA |
 |
Personalis
PSNL
|
639 K | $ 5.17 | -6.0 % | $ 306 M | USA |
 |
Senseonics Holdings
SENS
|
163 M | $ 6.72 | -6.41 % | $ 280 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 413.73 | 0.97 % | $ 11.9 B | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.6 | -1.75 % | $ 61.9 M |  Irlanda |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 115.5 | 12.69 % | $ 9.53 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 253.28 | -2.41 % | $ 21.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 57.4 | -2.96 % | $ 3.43 B | USA |
 |
NeoGenomics
NEO
|
435 M | $ 8.45 | -6.32 % | $ 1.08 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 119.85 | -0.18 % | $ 5.6 B | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 15.97 | -5.17 % | $ 357 M | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.64 | -4.03 % | $ 430 M | USA |
 |
Natera
NTRA
|
124 M | $ 193.57 | -3.3 % | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 187.94 | -3.61 % | $ 20.9 B | USA |
 |
Exagen
XGN
|
27.8 M | $ 2.66 | -2.56 % | $ 57.3 M | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
21.2 M | - | -16.95 % | $ 1.54 M | USA |